Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Amy A. Mrazek, Celia Chao

    Research output: Contribution to journalArticle

    Abstract

    The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

    Original languageEnglish (US)
    JournalThe Surgical clinics of North America
    Volume94
    Issue number5
    StatePublished - 2014

    Fingerprint

    Practice Management
    Melanoma
    Recurrence
    Skin
    Survivors
    Neoplasms
    Survival Rate
    Guidelines
    Neoplasm Metastasis
    Phenotype
    Mortality

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    @article{cc42a440cdc14c63aa8f0c709b65fb63,
    title = "Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.",
    abstract = "The number of melanoma survivors in the United States continues to steadily increase 2.6{\%} per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.",
    author = "Mrazek, {Amy A.} and Celia Chao",
    year = "2014",
    language = "English (US)",
    volume = "94",
    journal = "Surgical Clinics of North America",
    issn = "0039-6109",
    publisher = "W.B. Saunders Ltd",
    number = "5",

    }

    TY - JOUR

    T1 - Surviving cutaneous melanoma

    T2 - a clinical review of follow-up practices, surveillance, and management of recurrence.

    AU - Mrazek, Amy A.

    AU - Chao, Celia

    PY - 2014

    Y1 - 2014

    N2 - The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

    AB - The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

    UR - http://www.scopus.com/inward/record.url?scp=84909593284&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84909593284&partnerID=8YFLogxK

    M3 - Article

    C2 - 25245963

    VL - 94

    JO - Surgical Clinics of North America

    JF - Surgical Clinics of North America

    SN - 0039-6109

    IS - 5

    ER -